Princeton BioMolecules

Antibody


Home

Message

Company

Quotation

Antigenicity Prediction

Services

Products

Tech Info

 

Introduction

    Antibody is important in medical research and medical industry.  It is one of the most important tools for the diagnosis and components for the vaccine.  Peptide can be used as an antigen if it is conjugated to a big protein as a carrier.  Anti-peptide polyclonal antiserum production has become more important in our services.  Followings are some information of our services in this area.

Antigenicity Prediction

   Some peptide sequences are antigenic, some are not.  It is difficult to predict with 100% accuracy, because anitgenicity is a very complicate issue.  However many theories have been developed and many software programs are available to predict antigenicity of peptide sequences.  PBC has used a program for the service of this prediction.  It has been very much successful and many of our customers are quite satisfied.  If you like us to provide this service, you may visit our Antigenicity Prediction page.

Synthesis of Peptides

    Basically there are two kinds of peptides to use as an antigen. First kind is regular peptide which is synthesized and purified by HPLC to greater than 80% and 20 mg with QC of HPLC and MS. Second kind is MAP peptide which is prepared on a Lysine core of 20 mg with QC of HPLC.

Conjugation of Peptides

    MAP peptide does not need to conjugate to a carrier protein to be used as an antigen. However, conjugation is necessary for a small regular peptide. A peptide is conjugated to a carrier protein via a stable covalent bond: one side of the linker attaches to the protein through an amino group, the other side attaches to the peptide through an amino or a sulfhydryl group. The spacer between peptide and carrier protein is a group of six methylenes, -CH6- extended for a distance of 7.5 A, which allows the peptide more accessibility by sticking out from the area of carrier protein. The straight carbon chain also produces a clean background. The site for conjugation can be at the N- or C-terminal, or any point in the sequence of peptide. The conjugated product is delivered in a form of lyophilized power, which is easy to reconstitute.

Immunization Protocol

Day       Procedure                                  

01      Two NZW female rabbits
01      Prebleed , Primary SC/ID: 250ug with FCA
14     1st boost SC/IM: 250ug with FIA
28     2nd boost SC/IM: 250ug with FIA
42     3nd boost SC/IM: 250ug with FIA
52     1st production bleed
56     4nd boost SC/IM: 250ug with FIA
56     Shipping prebleed and 1st prod. bleed
66     2nd production bleed
70     Terminated bleed and exsanguination
70     Shipping 2nd prod. & terminated bleed

The above schedule may be extended with necessary procedures, such as boosts, bleeds, etc., to receive the best results according to customer's needs.

PBC also provides services to produce antiserum according to customer’s specified protocol.

Technical Information

PBC technical support group likes to discuss with customers about the specifications of peptides and antisera. We also provide information about the design of a peptide for antiserum production, such as antigenicities, synthetic difficulties, hydrophobic index, and others. For more information, please either visit our Tech Info page.

 

Back to Home Page        Contact Us

Princeton BioMolecules Corporation
2260 Cabot Blvd. West, Suite 4, Langhorne, PA 19047  USA
www.pbcpeptide.com     E-mail: info@pbcpeptide.com
Phone: 215-891-0415     Fax: 215-891-0419